Related Experiment Videos
Clinical oncologic positron emission tomography: an introduction
Timothy G Turkington1, R Edward Coleman
1Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Box 3949, DUMC, Durham, NC 27710, USA.
Seminars in Roentgenology
|July 24, 2002
Summary
Positron Emission Tomography (PET) imaging is rapidly advancing, offering high-quality scans with improved technology and wider availability. Increased clinical applications and payer recognition are driving a rise in annual PET scan performance.
Area of Science:
- Molecular imaging
- Radiochemistry
- Medical physics
Background:
- Positron Emission Tomography (PET) is a rapidly expanding molecular imaging technology.
- Advancements in detector materials and hybrid PET/CT systems enhance imaging quality and efficiency.
- Fluorodeoxyglucose (FDG) is widely accessible in U.S. hospitals.
Purpose of the Study:
- To highlight the increasing adoption and importance of PET imaging in clinical practice.
- To discuss the factors contributing to the growing use of PET scans.
- To project future trends in PET imaging utilization.
Main Methods:
- Review of current PET imaging technologies and radiopharmaceuticals.
- Analysis of trends in PET scan utilization and clinical indications.
- Assessment of healthcare payer perspectives on PET imaging.
Main Results:
- PET imaging offers high-quality images due to positron-emitting radionuclides like fluorine-18.
- Instrumentation improvements, including PET/CT combinations, enhance diagnostic capabilities.
- Growing recognition by third-party payers for PET's role in diagnosing malignancies.
Conclusions:
- PET imaging's accessibility, technological advancements, and clinical validation are driving its rapid diffusion.
- The increasing number of indications and improved instrumentation will lead to a continued rise in PET scan volumes.
- PET imaging is becoming an indispensable tool in modern diagnostic medicine.